Saccharomyces cerevisiae as a vaccine against coccidioidomycosis

Vaccine

Volumn 27, Issue 27, 2009, Pages 3662-3668

  Capilla, Javier ^a,b,c   Clemons, Karl V ^a,b,c   Liu, Min ^a,b,c   Levine, Hillel B ^a   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Coccidioidal vaccine; Coccidioides; Vaccines

Indexed keywords

ADJUVANT; BCG VACCINE; CPG OLIGODEOXYNUCLEOTIDE; FUNGUS VACCINE; IMJECT ALUM; INACTIVATED VACCINE; INTERLEUKIN 12; LIVE VACCINE; MURAMYL DIPEPTIDE; PHOSPHORYL LIPID A; RECOMBINANT VACCINE; SACCHAROMYCES CEREVISIAE VACCINE; SESAME SEED OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG POTENTIATION; HEAT KILLED SACCHAROMYCES CEREVISIAE; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; VACCINATION;

ANIMALS; COCCIDIOIDOMYCOSIS; FUNGAL VACCINES; HUMANS; MALE; MICE; SACCHAROMYCES CEREVISIAE; VACCINATION;

EID: 67349092447     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.030     Document Type: Article

References (49)

1. Chiller T.M., Galgiani J.N., and Stevens D.A. Coccidioidomycosis. Infect Dis Clin N Am 17 March (1) (2003) 41-57, viii
2. Levine H.B., Cobb J.M., and Smith C.E. Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J Immunol 87 August (1961) 218-227
3. Levine H.B., Kong Y.C., and Smith C. Immunization of mice to Coccidioides immitis: dose, regimen and spherulation stage of killed spherule vaccines. J Immunol 94 January (1965) 132-142
4. Levine H.B., Pappagianis D., and Cobb J.M. Development of vaccines for coccidioidomycosis. Mycopathol Mycol Appl 41 1 (1970) 177-185
5. Pappagianis D., and The Valley Fever Vaccine Study Group. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 148 3 (1993) 656-660
6. Cole G.T., Xue J.M., Okeke C.N., Tarcha E.J., Basrur V., Schaller R.A., et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 42 June (3) (2004) 189-216
7. Pappagianis D. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. Fungal Genet Biol 32 1 (2001) 1-9
8. Awasthi S. Dendritic cell-based vaccine against Coccidioides infection. Ann N Y Acad Sci 1111 September (2007) 269-274
9. Delgado N., Xue J., Yu J.J., Hung C.Y., and Cole G.T. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect Immun 71 June (6) (2003) 3010-3019
10. Jiang C., Magee D.M., and Cox R.A. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect Immun 67 11 (1999) 5848-5853
11. Jiang C., Magee D.M., Ivey F.D., and Cox R.A. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis. Infect Immun 70 July (7) (2002) 3539-3545
12. Jiang C., Magee D.M., Quitugua T.N., and Cox R.A. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA. Infect Immun 67 2 (1999) 630-635
13. Kirkland T.N., Finley F., Orsborn K.I., and Galgiani J.N. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect Immun 66 8 (1998) 3519-3522
14. Kirkland T.N., Thomas P.W., Finley F., and Cole G.T. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis. Infect Immun 66 2 (1998) 424-431
15. Pappagianis D., Hector R., Levine H.B., and Collins M.S. Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect Immun 25 1 (1979) 440-445
16. Zimmermann C.R., Johnson S.M., Martens G.W., White A.G., Zimmer B.L., and Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun 66 5 (1998) 2342-2345
17. Johnson S.M., Kerekes K.M., Lunetta J.M., and Pappagianis D. Characteristics of the protective subcellular coccidioidal T27K vaccine. Ann N Y Acad Sci 1111 September (2007) 275-289
18. Capilla J, Clemons KV, Stevens DA. The friend of man again? Saccharomyees(s) as a vaccine against invasive aspergillosis. 47th Intersci. Conf. Antimicrib. Agents Chemother. 2007 (Sept), Chicago, Abst. G-1708.
19. McCullough M.J., Clemons K.V., McCusker J.H., and Stevens D.A. Intergenic transcribed spacer PCR ribotyping for differentiation of Saccharomyces species and interspecific hybrids. J Clin Microbiol 36 April (4) (1998) 1035-1038
20. Levine H.B., and Kong Y.C. Immunologic impairment in mice treated intravenously with killed Coccidioides immitis spherules: suppressed response to intramuscular doses. J Immunol 97 3 (1966) 297-305
21. Shubitz L.F., Yu J.J., Hung C.Y., Kirkland T.N., Peng T., Perrill R., et al. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine 24 July (31-32) (2006) 5904-5911
22. Clemons K.V., Capilla J., and Stevens D.A. Experimental animal models of coccidioidomycosis. Ann N Y Acad Sci 1111 September (2007) 208-224
23. Clemons K.V., Hanson L.H., Perlman A.M., and Stevens D.A. Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis. Antimicrob Agents Chemother 34 5 (1990) 928-930
24. Lachin J.M. Worst-rank score analysis with informatively missing observations in clinical trials. Controlled Clin Trials 20 (1999) 408-422
25. Shih W. Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med 3 February (1) (2002) 4
26. Cox R.A., and Magee D.M. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev 17 October (4) (2004) 804-839 [table of contents]
27. Tarcha E.J., Basrur V., Hung C.Y., Gardner M.J., and Cole G.T. Multivalent recombinant protein vaccine against coccidioidomycosis. Infect Immun 74 October (10) (2006) 5802-5813
28. Shubitz L., Peng T., Perrill R., Simons J., Orsborn K., and Galgiani J.N. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect Immun 70 June (6) (2002) 3287-3289
29. Herr R.A., Hung C.Y., and Cole G.T. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis. Infect Immun 75 December (12) (2007) 5777-5787
30. Peng T., Shubitz L., Simons J., Perrill R., Orsborn K.I., and Galgiani J.N. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice. Infect Immun 70 July (7) (2002) 3330-3335
31. Clemons K.V., Leathers C.R., and Lee K.W. Systemic Coccidioides immitis infection in nude and beige mice. Infect Immun 47 3 (1985) 814-821
32. Kong Y.C., and Levine H.B. Experimentally induced immunity in the mycoses. Bacteriol Rev 31 March (1) (1967) 35-53
33. Rachini A., Pietrella D., Lupo P., Torosantucci A., Chiani P., Bromuro C., et al. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 75 November (11) (2007) 5085-5094
34. Torosantucci A., Bromuro C., Chiani P., De Bernardis F., Berti F., Galli C., et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202 September (5) (2005) 597-606
35. Casadevall A., and Pirofski L.A. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect Immun 75 November (11) (2007) 5074-5078
36. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8 January (1) (2007) 31-38
37. Brown G.D., and Gordon S. Fungal beta-glucans and mammalian immunity. Immunity 19 September (3) (2003) 311-315
38. Brown G.D., and Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol 7 April (4) (2005) 471-479
39. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116 April (4) (2006) 916-928
40. Bernstein M.B., Chakraborty M., Wansley E.K., Guo Z., Franzusoff A., Mostbock S., et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 26 January (4) (2008) 509-521
41. Cassone A., and Torosantucci A. Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine. Expert Rev Vac 5 December (6) (2006) 859-867
42. Cutler J.E., Deepe Jr. G.S., and Klein B.S. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev 5 January (1) (2007) 13-28
43. Bystricky S., Paulovicova E., and Machova E. Candida albicans mannan-protein conjugate as vaccine candidate. Immunol Lett 85 February (3) (2003) 251-255
44. Paulovicova E., Bystricky S., Masarova J., Machova E., and Mislovicova D. Immune response to Saccharomyces cerevisiae mannan conjugate in mice. Int Immunopharmacol 5 November (12) (2005) 1693-1698
45. Paulovicova E., Machova E., Tulinska J., and Bystricky S. Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate. Int Immunopharmacol 7 October (10) (2007) 1325-1333
46. Berner V.K., Sura M.E., and Hunter Jr. K.W. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations. Appl Microbiol Biotechnol 80 6 (2008) 1053-1061
47. Bizzini B., and Fattal-German M. Use of live Saccharomyces cerevisiae cells as a biological response modifier in experimental infections. FEMS Microbiol Immunol 2 October (3) (1990) 155-167
48. Orsborn K.I., Shubitz L.F., Peng T., Kellner E.M., Orbach M.J., Haynes P.A., et al. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate. Infect Immun 74 March (3) (2006) 1865-1872
49. Ito J.I., Lyons J.M., Hong T.B., Tamae D., Liu Y.K., Wilczynski S.P., et al. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. Infect Immun 74 September (9) (2006) 5075-5084